Biopsy, or Removal, that is The Question.
While William Shakespeare was not involved in writing the CPT coding rules, they can sometimes be just as hard to understand, if not harder, than the...
Coding Conundrum: SPRAVATO® (Eskatamine), Part 2
Welcome back to Coding Conundrum: SPRAVATO® (Eskatamine), Part 2! In part 1 I reviewed proper reporting for Spravato®, including drug administration....
Coding Conundrum: SPRAVATO® (Eskatamine), Part 1
In 2019, The U.S. Food and Drug Administration approved SPRAVATO® (Eskatamine) nasal spray to be used in conjunction with an oral anti-depressant for...
Additional Revenue Opportunity Coming in 2024!
Do you remember back in 2021 when CMS first proposed to implement G2211, office/outpatient E/M visit complexity add-on, but the effective date was...
Evaluation and Management (E/M) Coding Based on Time
In 2021 and 2023, time-based E/M service guidelines underwent significant revisions for office/outpatient and inpatient/observation services. The...